Skip to main content
    S

    Sabra Healthcare REIT Inc (SBRA)

    Official site

    REAL ESTATE • REIT - HEALTHCARE FACILITIES • NASDAQ

    $20.35
    -0.09 (-0.44%)

    Market Cap: $5.35B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Sabra Healthcare REIT Inc (SBRA) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Sabra Healthcare REIT (SBRA) has an FFO per share estimate of $1.67 for 2026. Analysts expect EPS of $0.33 for the fiscal year ending Dec 31, 2026, on revenue of $865.40M. Of 16 analysts, 6 rate the stock Buy or Strong Buy, 10 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 4 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 16 ratings average 2.56, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 38% of the ratings.

    RatingAnalystsShare
    Strong Buy16.3%
    Buy531.3%
    Hold1062.5%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Hold
    Total analysts
    16

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    FFO Estimates

    FFO per share is expected at $1.67 for 2026, up 8.4% from $1.54 in 2025, and at $1.71 for 2027, up 2.4%.

    FFO per share, 2026
    $1.67
    Estimate
    FFO per share, 2027
    $1.71
    Estimate
    Fiscal year ending Dec 31, 2026
    $0.33
    EPS consensus, revenue $865.40M
    Next report
    Feb 10, 2027
    Estimated
    Fiscal yearBasisFFO per shareChange
    2025Actual$1.54N/A
    2026Estimate$1.67+8.4%
    2027Estimate$1.71+2.4%
    These FFO per share estimates carry no analyst count, range or quarterly figures.

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 121.2% and revenue estimates rise 15.3%.

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.33$0.31 to $0.354$865.40M$575.13M to $957.05M5
    Dec 31, 2027$0.73$0.68 to $0.772$997.90M$630.13M to $1.14B8

    Quarterly Estimates

    The EPS consensus falls from $0.18 for the quarter ending Dec 31, 2026 to $0.16 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.18$0.16 to $0.2210$248.53M$214.23M to $273.60M12
    Mar 31, 2027$0.16$0.16 to $0.161$254.33M$241.13M to $272.94M6

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 3 upward and 4 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202614
    Fiscal year ending Dec 31, 202710
    Quarter ending Mar 31, 202710

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 49.2% from $0.65.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$0.33$0.40$0.45$0.48$0.65-49.8%
    Fiscal year ending Dec 31, 2027$0.73$0.81$0.81$0.81$0.78-6.7%
    Quarter ending Mar 31, 2027$0.16$0.20$0.20$0.20$0.18-11.1%

    Frequently Asked Questions About SBRA

    What is the SBRA stock forecast?

    Sabra Healthcare REIT's FFO per share estimate for 2026 is $1.67. Consensus analyst estimates put Sabra Healthcare REIT's EPS at $0.33 for the fiscal year ending Dec 31, 2026, on revenue of $865.40M. The consensus rating from 16 analysts is Hold.

    How do analysts rate SBRA stock?

    Of 16 analysts covering Sabra Healthcare REIT, 1 rates it Strong Buy, 5 Buy, 10 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from SBRA next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.33, with estimates from $0.31 to $0.35 from 4 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.73, with estimates from $0.68 to $0.77 from 2 analysts.

    What revenue do analysts expect from Sabra Healthcare REIT next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $865.40M, with estimates from $575.13M to $957.05M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $997.90M, with estimates from $630.13M to $1.14B.

    How many analysts cover SBRA?

    16 analysts rate Sabra Healthcare REIT stock, and 4 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.